(1)
METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN BY RP-HPLC. Journal of Pharmaceutical Negative Results 2022, 4316-4335. https://doi.org/10.47750/pnr.2022.13.S06.571.